Advertisement

Development and Validation of High-Throughput Crystallisation and Analysis (HTCAA) Methodology for Physical Form Screening

  • Rajni M. BhardwajEmail author
Chapter
Part of the Springer Theses book series (Springer Theses)

Abstract

High throughput crystallisation methodology for physical form screening using multi-well plate and Raman microscopy was developed and validated. This methodology offers various advantages including small sample requirement (~1 mg per crystallization), no sample preparation, rapid data acquisition using non-destructive analytical technique and rapid data analysis using chemometric techniques. The effectiveness of this methodology was assessed by applying it to three pharmaceutical molecules i.e. olanzapine, clozapine and amoxapine. Sixteen novel solid forms of olanzapine,  3 novel physical forms of clozapine and 10 novel salts of amoxapine were obtained by utilising a total of only ~640 mgs of API and ~65 ml of solvents. The developed methodology is an effective tool for preliminary investigation of solid-form diversity during early stages of drug development and provides data to guide further crystallization efforts in appropriate direction.

Keywords

Raman Spectrum Physical Form Fume Hood Raman Shift Polarise Light Microscopy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aaltonen J, Allesø M, Mirza S, Koradia V, Gordon KC, Rantanen J (2009) Solid form screening—a review. Eur J Pharm Biopharm 71:23–37CrossRefGoogle Scholar
  2. Accelrys (2010). Pipeline pilot in chemistry collection: basic chemistry user guide. Accelrys Inc., 5005 Wateridge Vista Drive, San Diego, CA 92121Google Scholar
  3. Al-Dulaimi S, Aina A, Burley J (2010) Rapid polymorph screening on milligram quantities of pharmaceutical material using phonon-mode Raman spectroscopy. CrystEngComm 12:1038–1040CrossRefGoogle Scholar
  4. Almarsson Ö, Hickey MB, Peterson ML, Morissette SL, Soukasene S, McNulty C, Tawa M, MacPhee JM, Remenar JF (2003) High-throughput surveys of crystal form diversity of highly polymorphic pharmaceutical compounds. Cryst Growth Des 3:927–933CrossRefGoogle Scholar
  5. Anderton C (2007) A valuable technique for polymorph screening. Am Pharm Rev 10:36–40Google Scholar
  6. Ashby CJ, Wang R (1996) Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24:349–394CrossRefGoogle Scholar
  7. Balbach S, Korn C (2004) Pharmaceutical evaluation of early development candidates “the 100 mg-approach”. Int J Pharm 275:1–12CrossRefGoogle Scholar
  8. Bastin RJ, Bowker MJ, Slater BJ (2000) Salt selection and optimisation procedures for pharmaceutical new chemical entities. Org Process Res Dev 4:427–435CrossRefGoogle Scholar
  9. Bugay DE (2001) Characterization of the solid-state: spectroscopic techniques. Adv Drug Deliv Rev 48:43–65CrossRefGoogle Scholar
  10. Clark SJ, Segall MD, Pickard CJ, Hasnip PJ, Probert MJ, Refson K, Payne MC (2005) First principles methods using CASTEP. Z Kristallogr 220:567–570Google Scholar
  11. Desrosiers PJ (2004) The potential of preform. Mod Drug Discov 7:40–43Google Scholar
  12. Findlay WP, Bugay DE (1998) Utilization of Fourier transform-Raman spectroscopy for the study of pharmaceutical crystal forms. J Pharm Biomed Anal 16:921–930CrossRefGoogle Scholar
  13. Florence AJ (2009) Approaches to high-throughput physical form screening and discovery. Polymorphism in pharmaceutical solids, vol 192. H. G. Brittain, Informa Healthcare, New York, pp 139–184Google Scholar
  14. Florence AJ, Johnston A, Price SL, Nowell H, Kennedy AR, Shankland N (2006) An automated parallel crystallisation search for predicted crystal structures and packing motifs of carbamazepine. J Pharm Sci 95:1918–1930CrossRefGoogle Scholar
  15. Gardner CR, Walsh CT, Almarsson O (2004) Drugs as materials: valuing physical form in drug discovery. Nat Rev Drug Discov 3:926–934CrossRefGoogle Scholar
  16. Hilfiker R, Berghausen J, Blatter F, Burkhard A, De Paul SM, Freiermuth B, Geoffroy A, Hofmeier U, Marcolli C, Siebenhaar B, Szelagiewicz M, Vit A, von Raumer M (2003) Polymorphism—integrated approach from high-throughput screening to crystallization optimization. J Therm Anal Calorim 73:429–440CrossRefGoogle Scholar
  17. Kastanos E, Kyriakides A, Hadjigeorgiou K, Pitris C (2012) A novel method for bacterial UTI diagnosis using Raman spectroscopy. Int J Spectrosc 2012:13CrossRefGoogle Scholar
  18. Kojima T, Onoue S, Murase N, Katoh F, Mano T, Matsuda Y (2006) Crystalline form information from multiwell plate salt screening by use of Raman microscopy. Pharm Res 23:806–812CrossRefGoogle Scholar
  19. Kojima T, Tsutsumi S, Yamamoto K, Ikeda Y, Moriwaki T (2010) High-throughput cocrystal slurry screening by use of in situ Raman microscopy and multi-well plate. Int J Pharm 399:52–59CrossRefGoogle Scholar
  20. Lowry S, Dalrymple D, Song A, Rosso V, Pommier C, Venit J (2006) Integrating a Raman microscope into the workflow of a high-throughput crystallization laboratory. J Assoc Lab Autom 11:75–84CrossRefGoogle Scholar
  21. Matousek P, Towrie M, Parker AW (2002) Fluorescence background suppression in Raman spectroscopy using combined Kerr gated and shifted excitation Raman difference techniques. J Raman Spectrosc 33:238–242CrossRefGoogle Scholar
  22. Morissette SL, Soukasene S, Levinson D, Cima MJ, Almarsson Ö (2003) Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization. Proc Natl Acad Sci 100:2180–2184CrossRefGoogle Scholar
  23. Morissette SL, Almarsson Ö, Peterson ML, Remenar JF, Read MJ, Lemmo AV, Ellis S, Cima MJ, Gardner CR (2004) High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. Adv Drug Deliv Rev 56:275–300CrossRefGoogle Scholar
  24. Norris KH, Williams PC (1984) Optimization of mathematical treatments of raw near-infrared signal in the measurement of protein in hard red spring wheat. 1. Influence of particle-size. Cereal Chem 61:158–165Google Scholar
  25. O’Connell M-L, Howley T, Ryder AG, Leger MN, Madden MG (2005) Classification of a target analyte in solid mixtures using principal component analysis, support vector machines, and Raman spectroscopy. SPIE Proc 5826:340–350CrossRefGoogle Scholar
  26. Petcher TJ, Weber H-P (1976) Conformations of some semi-rigid neuroleptic drugs. Part 1. Crystal structures of loxapine, clozapine, and HUF-2046 monohydrate {2-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b, f][1,4]oxazepine, 8-chloro-11-(4-methylpiperazin-1-yl)dibenzo[b, e][1,4]diazepine, and 2-chloro-11(4-methylpiperazin-1-yl)dibenzo[b, e][1,4]diazepine monohydrate}. J Chem Soc Perkin Trans 2:1415–1420CrossRefGoogle Scholar
  27. Peterson ML, Morissette SL, McNulty C, Goldsweig A, Shaw P, LeQuesne M, Monagle J, Encina N, Marchionna J, Johnson A, Gonzalez-Zugasti J, Lemmo AV, Ellis SJ, Cima MJ, Almarsson Ö (2002) Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III. J Am Chem Soc 124:10958–10959CrossRefGoogle Scholar
  28. Pommier CJ, Rosso V, Song A (2005) Challenges in data analysis of Raman spectra from crystallization in 96 wellplates. Am Pharm Rev 8:19–24Google Scholar
  29. Price CP, Grzesiak AL, Matzger AJ (2005) Crystalline polymorph selection and discovery with polymer heteronuclei. J Am Chem Soc 127:5512–5517CrossRefGoogle Scholar
  30. Remenar JF, MacPhee JM, Larson BK, Tyagi VA, Ho JH, McIlroy DA, Hickey MB, Shaw PB, Almarsson Ö (2003) Salt selection and simultaneous polymorphism assessment via high-throughput crystallization: the case of sertraline. Org Process Res Dev 7:990–996CrossRefGoogle Scholar
  31. Romero-Torres S, Huang J, Hernandez-abad PE (2009) Practical considerations in PAT analyzer selection: NIR vs. Raman. Am Pharm Rev. http://www.americanpharmaceuticalreview.com/Featured-Articles/117780-Practical-Considerations-on-PAT-Analyzer-Selection-Raman-vs-NIR-Spectroscopy/
  32. Siva Lakshmi D, Prasunambaa PL, Ravikumarb K, Sridharb B (2011) Solid state characterization of clozapine monohydrate. Struct Chem Commun 2:101–104Google Scholar
  33. Smith E, Dent G (2005a) Introduction, basic theory and principles. Modern Raman spectroscopy—a practical approach. Wiley, London, pp 1–21Google Scholar
  34. Smith E, Dent G (2005b) Resonance Raman scattering. Modern Raman spectroscopy—a practical approach. Wiley, London, pp 93–112Google Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Lilly Corporate CenterEli Lilly and CompanyIndianapolisUSA

Personalised recommendations